PATENT CLAIM ANALYSIS

Application Number: 16075240
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "315000"]

Abstract:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.

Claim (Index 4):
The compound according to  claim 1 , wherein R 1  is an acyl group, or a salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.39535
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16049359', '15933889', '14779347', '14898633', '14566157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8200820672917642
- 35 USC 102 Novelty (BERT): 0.5331157574676172
- Combined Prediction Score: 0.7913854363093495
- Mean Citation Score: 359.833626
- Max Citation Score: 364.97223
- Similarity Product: 278.6376670969749

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test